News
The Canadian Press on MSN51m
Research on gene therapy for rare inherited disease reduces costly, regular treatmentA researcher says an experimental gene therapy for a rare inherited disorder is saving almost as much money for the treatment ...
Here, Michelle Tsai – chief operating officer at iOnctura – and Shane Olwill – chief development officer at Asgard ...
The approval comes amid speculation that AstraZeneca CEO Pascal Soriot is considering delisting its UK stock market listing for the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback